Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer: a population-wide cohort study.

ESMO Gastrointest Oncol · 2024 · PMC12836779 · PMID 41648034

Europe PMC DOI

hedged sentence

0.0528

closest p · 1.1× alpha

0.0528

boldest claim

The sentences

borderline significanceP = 0.0528so close (0.05 < p ≤ 0.1)

The interaction of sidedness with KRAS mutation exhibited borderline significance in the Cox model for TTD ( P = 0.0528) and significance in the model for OS ( P = 0.0010).

also in 4,352 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.